Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

9.28
-0.0600-0.64%
Post-market: 9.280.00000.00%17:17 EST
Volume:660.76K
Turnover:6.09M
Market Cap:917.32M
PE:-11.38
High:9.33
Open:9.12
Low:9.05
Close:9.34
52wk High:18.90
52wk Low:6.66
Shares:98.85M
Float Shares:55.27M
Volume Ratio:0.83
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8154
EPS(LYR):0.0800
ROE:-45.92%
ROA:-19.22%
PB:6.21
PE(LYR):116.00

Loading ...

Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 25, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Sep 02, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 01, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities